Vaccine against shingles Zostavax

Merck & Co. Faces Nearly 2000 Zostavax Vaccine Lawsuits

August 30, 2021 — Merck & Co. won the first “bellwether” trial involving Zostavax in a federal Multi-District Litigation (MDL #2848) in Pennsylvania.

The trial involved a man from Florida who developed shingles 8 years after he received the Zostavax vaccine in 2008. His lawyers failed to provide an expert witness by March 2021, so the case was tossed.

Merck was granted summary judgement by U.S. Judge Harvey Bartle III of the Eastern District of Pennsylvania — but the saga is not over.

His lawsuit was one of 6 cases in a pool of lawsuits that Merck faces. The next trials are scheduled to begin in January 2022

Furthermore, Merck & Co. is still facing around 1,950 lawsuits over its shingles shot Zostavax in the federal MDL.

Merck is accused of failing to warn about the risk of severe side effects, including an infection with the virus in Zostavax that can cause shingles — the very same disease it was supposed to prevent.

There have also been reports of death in immunocompromised people who developed serious infections from the virus in the vaccine.

Lawyers for people who developed these side effects claim that the virus was not adequately weakened to prevent serious infections.

Source: Merck scores a win in bellwether Zostavax case, but nearly 2,000 remain

Vaccine Side Effects & Injury Lawyers

Verified 100% Secure Site

If you or a loved one has been the victim of a vaccine side effect, you should contact a vaccine lawyer with experience in this type of complex litigation.

We have recently partnered with Schmidt & Clark, LLP; a Nationally recognized law firm who handles vaccine lawsuits in all 50 states.

The lawyers at the firm offer a Free Confidential Case Evaluation and may be able to obtain financial compensation for you or a loved one by filing a vaccine lawsuit or claim with The National Vaccine Injury Compensation Program. Contact Schmidt & Clark today by using the form below or by calling them directly at (866) 223-3784.

Previous Article

Leave a Reply

Your email address will not be published. Required fields are marked *